KA Imaging Signs with Alpha Imaging for Distribution in the USA

KA Imaging has signed a distribution agreement in the USA with Alpha Imaging. Hospitals, medical facilities, and practices from 14 states can now acquire Reveal™ 35C through Alpha Imaging, one of the largest distributors of medical imaging equipment in the country.

Robert Moccia, VP of Sales for KA Imaging in the United States and Canada, is thrilled to have made this agreement.

“Our partnership with Alpha is a big step towards KA Imaging’s vision to bring innovative X-ray everywhere. Alpha Imaging’s 30+ year track record of providing Imaging equipment to some of the most prestigious healthcare institutions in the US gives KA Imaging the access and credibility to excite the market with our technology and ultimately improve patient care” said Moccia.

Michael Perrico, CEO of Alpha Imaging, said: “The addition of KA Imaging’s Reveal 35C adds yet another advanced imaging technology to our robust portfolio of medical imaging offerings. Single exposure subtracted chest imaging will provide clients with a low dose and cost-effective alternative to traditional dual-energy systems. We are excited to partner with KA Imaging.”

Reveal 35C is the world’s first and only portable dual-energy X-ray detector. The detector provides radiologists with three unobstructed images in a single shot that are free from motion artifacts. Reveal is currently being used in two clinical trials, for detecting both lung cancer and pneumonia (including COVID-19) with great initial success.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.